Psychemedics Investor Relations Material

Psychemedics Corporation specializes in providing drug testing services through the analysis of hair samples for detecting drugs of abuse. This includes a broad range of substances such as cocaine, marijuana, PCP, amphetamines (including ecstasy and Adderall), opiates (like heroin and oxycodone), synthetic cannabinoids (e.g., K2 and Spice), benzodiazepines (such as Xanax and Valium), as well as nicotine, fentanyl, and alcohol. The company's testing results offer quantitative information that can indicate the approximate amount of drug ingested and historical data to show a pattern of individual drug use over time. Psychemedics' services cater to various sectors including employers for applicant and employee testing, treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation is headquartered in Dallas, Texas, and its shares are listed on the Nasdaq.